Literature DB >> 32669878

Trend Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in 16 Cities of Hubei Province, China.

Muhammad Fawad1,2, Sumaira Mubarik3, Saima Shakil Malik4, Yangyang Hao2, Chuanhua Yu3, Jingli Ren1.   

Abstract

OBJECTIVE: A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected by researchers from a patient in Wuhan, Hubei province, China, in December 2019, and broke out in January 2020. Then, the pandemic was detected in countries around the world. Therefore, precise estimates of its current and future trends are highly required for future policy implications.
METHODS: We retrieved data from the Health Commission of Hubei, China. Logistic-S curve model was used to estimate the current and future trends of SARS-CoV-2-infected cases among 16 cities of Hubei, China from Jan-11 to Feb-24, 2020.
RESULTS: Out of 64,287 confirmed cases of SARS-CoV-2 infection in Hubei, higher percentage of cases were in Wuhan and Xiaogan. The highest death percentage was found in Wuhan and Qianjiang. A significant percentage of cures were found in Enshi Prefecture and Huanggang, while Wuhan showed the lowest percentage of cures. Rising trends in infected cases were observed throughout the study period, particularly in Wuhan, and a higher trend was observed after 12-Feb. Gradual decline trend of SARS-CoV-2 cases was observed during Feb-25 to Mar-15 in Hubei Province. Future forecast showed that the average number of SARS-CoV-2-infected cases might be decreased or stable in Hubei in the coming 20 days.
CONCLUSION: The public must take precautionary measures in order to control and prevent disease spread and avoid extra travelling.
© 2020 Fawad et al.

Entities:  

Keywords:  China; SARS-CoV-2; Wuhan; cities; death; trends

Year:  2020        PMID: 32669878      PMCID: PMC7337437          DOI: 10.2147/CLEP.S254806

Source DB:  PubMed          Journal:  Clin Epidemiol        ISSN: 1179-1349            Impact factor:   4.790


  35 in total

Review 1.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

2.  Therapeutic options for the 2019 novel coronavirus (2019-nCoV).

Authors:  Guangdi Li; Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2020-03       Impact factor: 84.694

3.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

Review 4.  Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells.

Authors:  Jean Kaoru Millet; Gary R Whittaker
Journal:  Virology       Date:  2017-12-21       Impact factor: 3.616

5.  Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase.

Authors:  Muhammad Usman Mirza; Matheus Froeyen
Journal:  J Pharm Anal       Date:  2020-04-28

6.  First Case of 2019 Novel Coronavirus in the United States.

Authors:  Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai
Journal:  N Engl J Med       Date:  2020-01-31       Impact factor: 91.245

7.  Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus.

Authors:  Ben Hu; Lei-Ping Zeng; Xing-Lou Yang; Xing-Yi Ge; Wei Zhang; Bei Li; Jia-Zheng Xie; Xu-Rui Shen; Yun-Zhi Zhang; Ning Wang; Dong-Sheng Luo; Xiao-Shuang Zheng; Mei-Niang Wang; Peter Daszak; Lin-Fa Wang; Jie Cui; Zheng-Li Shi
Journal:  PLoS Pathog       Date:  2017-11-30       Impact factor: 6.823

Review 8.  Antiviral treatment of COVID-19

Authors:  Serap Şimşek Yavuz; Serhat Ünal
Journal:  Turk J Med Sci       Date:  2020-04-15       Impact factor: 0.973

9.  COVID-19: combining antiviral and anti-inflammatory treatments.

Authors:  Justin Stebbing; Anne Phelan; Ivan Griffin; Catherine Tucker; Olly Oechsle; Dan Smith; Peter Richardson
Journal:  Lancet Infect Dis       Date:  2020-02-27       Impact factor: 25.071

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more
  2 in total

1.  Statistical analysis of COVID-19 infection caused by environmental factors: Evidence from Pakistan.

Authors:  Muhammad Fawad; Sumaira Mubarik; Saima Shakil Malik; Jingli Ren
Journal:  Life Sci       Date:  2021-01-18       Impact factor: 6.780

2.  A Framework for a Statistical Characterization of Epidemic Cycles: COVID-19 Case Study.

Authors:  Eduardo Atem De Carvalho; Rogerio Atem De Carvalho
Journal:  JMIRx Med       Date:  2021-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.